Publication | Open Access
Antifungal Activity Evaluation of the Constituents of Haliclona baeri and Haliclona cymaeformis, Collected from the Gulf of Thailand
48
Citations
13
References
2007
Year
Pharmaceutical ScienceSecondary MetaboliteNew Compound Maleimide-5-oximeHaliclona BaeriPharmaceutical ChemistryHmbc CorrelationsMedicinal ChemistryAnti-cancer AgentAntifungal Activity EvaluationBiochemistryAntifungal AgentsAntimicrobial CompoundPharmacologyAntifungal AgentFilamentous FungiNatural SciencesDrug DiscoveryMicrobiologyMedicineHaliclona Cymaeformis
A new compound maleimide-5-oxime was isolated, together with 3,4-dihydroxybenzoic acid, tetillapyrone, from the ethyl acetate extract of the marine sponge Haliclona baeri while tetillapyrone, nortetillapyrone, p-hydroxybenzaldehyde and phenylacetic acid were isolated from the ethyl acetate extract of Haliclona cymaeformis, collected from the Gulf of Thailand. The structures of tetillapyrone and nortetillapyrone were re-examined using HMBC correlations. Maleimide-5-oxime, tetillapyrone and nortetillapyrone were found to be inactive against three human tumor cell lines (the estrogen-dependent ER(+) MCF-7, the estrogen-independent ER(-) MDA-MB-231 and NCI-H460. Maleimide-5-oxime, p-hydroxybenzaldehyde, phenylacetic acid, tetillapyrone and nortetillapyrone were evaluated for their growth inhibitory effect against seven yeasts and eight filamentous fungi. Only nortetillapyrone showed antifungal activity, with a preponderance on the dermatophytic filamentous fungi.
| Year | Citations | |
|---|---|---|
Page 1
Page 1